Multiple mechanisms may contribute to the development of ulcers in APS patients (Figure 3): 1.: aPLs may directly activate the mTOR pathway by affecting the function of endothelial cells and platelets, leading to the activation of mTOR signaling. Here, MTOR is linked to autoimmune polyendocrinopathy.